Angela A. Dispenzieri

Hematology
200 1st St SW
Rochester, MN 55905

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 825 publications

124I-Evuzamitide Positron Emission Tomography/Computed Tomography for Diagnosing Cardiac Amyloidosis: The REVEAL Nonrandomized Clinical Trial.

124I-Evuzamitide Positron Emission Tomography/Computed Tomography for Diagnosing Cardiac Amyloidosis: The REVEAL Nonrandomized Clinical Trial.

Journal: JAMA
Published: August 30, 2026

Utility of Prognostic Staging Systems in Transthyretin Amyloidosis Cardiomyopathy in the Era of Available Disease-Modifying Treatment.

Utility of Prognostic Staging Systems in Transthyretin Amyloidosis Cardiomyopathy in the Era of Available Disease-Modifying Treatment.

Journal: Journal of the American Heart Association
Published: August 07, 2026

Erratum: Efficacy and Safety of Anselamimab in Immunoglobulin Light Chain Amyloidosis: Results From the Randomized CARES Trials.

Erratum: Efficacy and Safety of Anselamimab in Immunoglobulin Light Chain Amyloidosis: Results From the Randomized CARES Trials.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 03, 2026

Pathology-Based Validation of Quantitative SPECT/CT in Patients With Suspected Transthyretin Amyloid Cardiomyopathy.

Pathology-Based Validation of Quantitative SPECT/CT in Patients With Suspected Transthyretin Amyloid Cardiomyopathy.

Journal: Circulation. Cardiovascular imaging
Published: July 23, 2026

Treating Castleman disease: insights into the use and efficacy of monoclonal antibodies.

Treating Castleman disease: insights into the use and efficacy of monoclonal antibodies.

Journal: Expert opinion on biological therapy
Published: July 09, 2026

Diagnostic Accuracy of Fat Pad Sampling and Bone Marrow Biopsy for AL Amyloidosis: A Systematic Review and Meta-Analysis.

Diagnostic Accuracy of Fat Pad Sampling and Bone Marrow Biopsy for AL Amyloidosis: A Systematic Review and Meta-Analysis.

Journal: Blood advances
Published: July 08, 2026

Reply: Biochemical Remission and Residual Cardiac Abnormalities in AL Amyloidosis.

Reply: Biochemical Remission and Residual Cardiac Abnormalities in AL Amyloidosis.

Journal: JACC. CardioOncology
Published: June 28, 2026

Bioepidemiology of cardiac amyloidosis.

Bioepidemiology of cardiac amyloidosis.

Journal: Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology
Published: June 12, 2026

Prevalence and Burden of Cardiac Amyloidosis in a Population-Based Autopsy Cohort.

Prevalence and Burden of Cardiac Amyloidosis in a Population-Based Autopsy Cohort.

Journal: Circulation
Published: June 08, 2026

POEMS Syndrome: 2026 Update on Diagnosis, Risk-Stratification, and Management.

POEMS Syndrome: 2026 Update on Diagnosis, Risk-Stratification, and Management.

Journal: American journal of hematology
Published: June 05, 2026

Chromosome 1q Gain Defines a Plasma Cell-Dominant Adverse-Risk Subtype in AL Amyloidosis With Inferior Long-Term Survival.

Chromosome 1q Gain Defines a Plasma Cell-Dominant Adverse-Risk Subtype in AL Amyloidosis With Inferior Long-Term Survival.

Journal: American journal of hematology
Published: May 30, 2026

Efficacy and Safety of Anselamimab in Immunoglobulin Light Chain Amyloidosis: Results From the Randomized CARES Trials.

Efficacy and Safety of Anselamimab in Immunoglobulin Light Chain Amyloidosis: Results From the Randomized CARES Trials.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 29, 2026
Showing 1-12 of 825

Last Updated: 09/26/2026